Executive Director
Amgen
Dr. Rellahan is an Executive Director in the Product Quality organization at Amgen. She manages a team of Product Quality Leaders with quality oversight of Amgen's biosimilar and originator products including the establishment of specifications, comparability analyses, and product stability programs. Dr. Rellahan also has oversight of Amgen’s Global CMC Statistics Team. Dr. Rellahan holds a MS in Cell Biology and a PhD in Immunology. Prior to joining Amgen in 2013, Dr. Rellahan was a CMC regulatory reviewer and team leader in the Office of Biotechnology Products (OBP), FDA.